These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 21685607

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The EU-ADR project: preliminary results and perspective.
    Trifiro G, Fourrier-Reglat A, Sturkenboom MC, Díaz Acedo C, Van Der Lei J, EU-ADR Group.
    Stud Health Technol Inform; 2009; 148():43-9. PubMed ID: 19745234
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Electronic healthcare databases for active drug safety surveillance: is there enough leverage?
    Coloma PM, Trifirò G, Schuemie MJ, Gini R, Herings R, Hippisley-Cox J, Mazzaglia G, Picelli G, Corrao G, Pedersen L, van der Lei J, Sturkenboom M, EU-ADR Consortium.
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):611-21. PubMed ID: 22315152
    [Abstract] [Full Text] [Related]

  • 6. A computerized system for signal detection in spontaneous reporting system of Shanghai China.
    Ye X, Fu Z, Wang H, Du W, Wang R, Sun Y, Gao Q, He J.
    Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):154-8. PubMed ID: 19115240
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project.
    Coloma PM, Schuemie MJ, Trifirò G, Gini R, Herings R, Hippisley-Cox J, Mazzaglia G, Giaquinto C, Corrao G, Pedersen L, van der Lei J, Sturkenboom M, EU-ADR Consortium.
    Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):1-11. PubMed ID: 21182150
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database.
    Shalviri G, Mohammad K, Majdzadeh R, Gholami K.
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1136-40. PubMed ID: 17705214
    [Abstract] [Full Text] [Related]

  • 19. Detection of adverse drug reaction signals using an electronic health records database: Comparison of the Laboratory Extreme Abnormality Ratio (CLEAR) algorithm.
    Yoon D, Park MY, Choi NK, Park BJ, Kim JH, Park RW.
    Clin Pharmacol Ther; 2012 Mar; 91(3):467-74. PubMed ID: 22237257
    [Abstract] [Full Text] [Related]

  • 20. Can Electronic Health Records Databases Complement Spontaneous Reporting System Databases? A Historical-Reconstruction of the Association of Rofecoxib and Acute Myocardial Infarction.
    Patadia VK, Schuemie MJ, Coloma PM, Herings R, van der Lei J, Sturkenboom M, Trifirò G.
    Front Pharmacol; 2018 Mar; 9():594. PubMed ID: 29928230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.